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Microvascular immunologic injury which is an early sequaelum of solid organ 
irnmumosuppression and OKT3 induction therapy. SequentiJ bropsres (~otal=22) 
were obtained in 3 patients dtwng the initial 12 we& following u-ansplantation. 
Micfovasr&r antigen expn%sion was assessed using immuno~oxidase techniques 
with monoclot@ antibodies D endothclial cells (El.5 + Al) and MHC antgcns 
@LA ABC, DR. DP + IX& Antigen expression was gmdcd O-5 by tr\a, ohscrvea. 
Qopp1e.r who sludies were performed within 24 hours of wh biopsy and analyzed 
without knowledge of biopsy resuhs. Regression analysis examined Ihc relationship 
between each functional index (IVRT. PWT. Ml) to antigen exprcssmn. 
C showed no correlation with graft functton. 5 in IVRT and 7 in 
M1 were linearly r&led to expression of microvascular antigens. I in PHT 
correlated with 1 Al expression. 
7ltc.% pesults support the hypolhcsis tit immune injury msy manifest as micro- 
vascular irtjury, altering vascular permeability and resultmg in myocyte 
dysfunction. These factors may be important in the patiogenesis and di~gnasis of 
acute n&xion. 
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Plasma VOIE Willebrand”s factor (vWF) is a marker of dis- 
ease severity in the systemic vasculitides and endothelial 
injury e We have assessed vWF as a marker of rejection. 
Sfx consecutive heart transplant recipients were each 
followed for three months after transplantation. Serial 
measurements of vWF and an acute phase protein, C-reactive 
protein (CRP) were assayed using an ELISA technique. 
Post-transplantation levels of CRF and vWF peaked ani fell, 
with CRP levels returning to normal by days lo-50 and vWF 
levels settling at a stable levels of 2.5-4.5 ID/ml 
(normal range 0.5-1.4). There were 11 rejection episodes. 
All four rejection episodes where cardiac biopsy showed 
moderate or sever@ rejection were associated with a rise 
in vWF levels of greater than 1 III/ml above the baseline 
without a coincident rise in CRP. In three rejcction cpi- 
sodas where cardiac biopsy showed mild rejectisn, only one 
of three showed a similar rise in vWF, none shored .a rise 
in CRP. 
cal 
Four rejection episodes were diagnosed by clini- 
criteria alone In the early post-ope-ative period, two 
were associated with increased vWF and one of these had a 
concomitant rise in CRP. Three patients had CMV infections, 
all showed a rise in vWF levels, with an initial concomi- 
tant rise in CRP in two. In conclusion9 our early result 
suggest that increases of vWF levels withou; increases in 
CRP levels have a lOOf sensitivity and 80% specificity for 
moderate to severe rejection episodes. Increases in both 
vWF and CRP are suggestive of infective episodes. These 
findings merit further study of vWF and CRP as discrimin- 
ating markers of rejection and infection. 
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